Department of Molecular Medicine, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, N-0317 Oslo, Norway.
Department of Nutrition, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, N-0317 Oslo, Norway.
Cells. 2020 May 13;9(5):1214. doi: 10.3390/cells9051214.
The cholesterol-sensing nuclear receptor liver X receptor (LXR) and the glucose-sensing transcription factor carbohydrate responsive element-binding protein (ChREBP) are central players in regulating glucose and lipid metabolism in the liver. More knowledge of their mechanistic interplay is needed to understand their role in pathological conditions like fatty liver disease and insulin resistance. In the current study, LXR and ChREBP co-occupancy was examined by analyzing ChIP-seq datasets from mice livers. LXR and ChREBP interaction was determined by Co-immunoprecipitation (CoIP) and their transactivity was assessed by real-time quantitative polymerase chain reaction (qPCR) of target genes and gene reporter assays. Chromatin binding capacity was determined by ChIP-qPCR assays. Our data show that LXRα and ChREBPα interact physically and show a high co-occupancy at regulatory regions in the mouse genome. LXRα co-activates ChREBPα and regulates ChREBP-specific target genes in vitro and in vivo. This co-activation is dependent on functional recognition elements for ChREBP but not for LXR, indicating that ChREBPα recruits LXRα to chromatin in . The two factors interact via their key activation domains; the low glucose inhibitory domain (LID) of ChREBPα and the ligand-binding domain (LBD) of LXRα. While unliganded LXRα co-activates ChREBPα, ligand-bound LXRα surprisingly represses ChREBPα activity on ChREBP-specific target genes. Mechanistically, this is due to a destabilized LXRα:ChREBPα interaction, leading to reduced ChREBP-binding to chromatin and restricted activation of glycolytic and lipogenic target genes. This ligand-driven molecular switch highlights an unappreciated role of LXRα in responding to nutritional cues that was overlooked due to LXR lipogenesis-promoting function.
胆固醇感应核受体肝 X 受体 (LXR) 和葡萄糖感应转录因子碳水化合物反应元件结合蛋白 (ChREBP) 是调节肝脏葡萄糖和脂质代谢的核心分子。为了更好地理解它们在脂肪肝和胰岛素抵抗等病理状态下的作用,需要更多地了解它们的机制相互作用。在本研究中,通过分析小鼠肝脏的 ChIP-seq 数据集,研究了 LXR 和 ChREBP 的共占据情况。通过免疫共沉淀 (CoIP) 确定了 LXR 和 ChREBP 的相互作用,通过实时定量聚合酶链反应 (qPCR) 检测靶基因和基因报告基因检测评估了它们的转录活性。通过 ChIP-qPCR 检测确定了染色质结合能力。我们的数据表明,LXRα 和 ChREBPα 物理相互作用,并在小鼠基因组的调控区域显示出高度的共占据。LXRα 在体外和体内共激活 ChREBPα 并调节 ChREBP 特异性靶基因。这种共激活依赖于 ChREBP 的功能识别元件,但不依赖于 LXR,表明 ChREBPα 将 LXRα 募集到染色质中。这两个因子通过它们的关键激活结构域相互作用;ChREBPα 的低葡萄糖抑制结构域 (LID) 和 LXRα 的配体结合结构域 (LBD)。虽然未配体结合的 LXRα 共激活 ChREBPα,但配体结合的 LXRα 出人意料地抑制了 ChREBPα 在 ChREBP 特异性靶基因上的活性。从机制上讲,这是由于 LXRα:ChREBPα 相互作用的不稳定,导致 ChREBPα 与染色质的结合减少,糖酵解和脂肪生成靶基因的激活受限。这种配体驱动的分子开关突出了 LXRα 在响应营养线索方面的未被认识到的作用,由于 LXR 促进脂肪生成的功能,这一作用被忽视了。